drugset / Trial / NCT04588649

The Aging Brain and Cognition: Contribution of Vascular Injury, Amyloid Plaque and Tau Protein to Cognitive Dysfunction After Stroke

NCT04588649

Phase 2 Completed 181 enrolled Chang Gung Memorial Hospital
Non-randomizedParallel-groupSingle-blindDiagnostic

Summary

Stroke can lead to signficiant neurological deficits, and about one-third of stroke patients will be diagnosed of vascular mild cognitive impairment or post-stroke dementia. Post-stroke dementia includes all types of dementia that happen after stroke, irrespective of their cause, and vascular dementia (VaD), degenerative dementia (especially Alzheimer's disease), or mixed dementia (dementia as a result of the coexistence of vascular lesions of the brain and neurodegenerative lesions) are the most common causes of post-stroke dementia. However, it is difficult to determine to what extent cognitive impairment may be attributable to stroke versus concomitant Alzheimer disease. With the advent of PET imaging technique, we are able to conduct a multi-modal neuroimaging study to explore the composite influence of vascular injury, amyloid plaque and Tau protein the the cognitive performance after stroke.

Timeline

Start
2016-01-04
Primary completion
2016-03-29
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject THK5351 Small molecule 10 mbq Intravenous
Subject florbetapir Diagnostic / imaging agent 10 mbq Intravenous